Suche Bilder Maps Play YouTube News Gmail Drive Mehr »
Anmelden
Nutzer von Screenreadern: Klicke auf diesen Link, um die Bedienungshilfen zu aktivieren. Dieser Modus bietet die gleichen Grundfunktionen, funktioniert aber besser mit deinem Reader.

Patentsuche

  1. Erweiterte Patentsuche
VeröffentlichungsnummerUS20040133079 A1
PublikationstypAnmeldung
AnmeldenummerUS 10/334,283
Veröffentlichungsdatum8. Juli 2004
Eingetragen2. Jan. 2003
Prioritätsdatum2. Jan. 2003
Auch veröffentlicht unterUS8628471, US20100268095
Veröffentlichungsnummer10334283, 334283, US 2004/0133079 A1, US 2004/133079 A1, US 20040133079 A1, US 20040133079A1, US 2004133079 A1, US 2004133079A1, US-A1-20040133079, US-A1-2004133079, US2004/0133079A1, US2004/133079A1, US20040133079 A1, US20040133079A1, US2004133079 A1, US2004133079A1
ErfinderScott Mazar, Richard Fogoros, Yatheendhar Manicka, Bruce KenKnight, Michael Pederson
Ursprünglich BevollmächtigterMazar Scott Thomas, Richard Fogoros, Yatheendhar Manicka, Kenknight Bruce H., Pederson Michael J.
Zitat exportierenBiBTeX, EndNote, RefMan
Externe Links: USPTO, USPTO-Zuordnung, Espacenet
System and method for predicting patient health within a patient management system
US 20040133079 A1
Zusammenfassung
Systems and Methods for predicting patient health and patient relative well-being within a patient management system are disclosed. A preferred embodiment utilizes an implantable medical device comprising an analysis component and a sensing component further comprising a three-dimensional accelerometer, a transthoracic impedance sensor, a cardio-activity sensor, an oxygen saturation sensor and a blood glucose sensor. Some embodiments of a system disclosed herein also can be configured as an Advanced Patient Management System that helps better monitor, predict and manage chronic diseases.
Bilder(9)
Previous page
Next page
Ansprüche(101)
What is claimed is:
1. A system for predicting patient health and well-being within a patient management system comprising a medical device further comprising:
a. a sensing component in electronic communication with other components of the system including one or more sensors adapted to sense physiological function data;
b. an analysis component in electronic communication with other components of the system adapted to analyze the sensed physiological data; and
c. a communications component in electronic communication with other components of the system adapted to communicate the sensed or analyzed physiological data.
2. The medical device of claim 1, wherein the device is an implantable medical device.
3. The sensing component of claim 1, wherein the sensing component comprises an accelerometer.
4. The accelerometer of claim 3, wherein the accelerometer comprises a one-dimensional accelerometer.
5. The accelerometer of claim 3, wherein the accelerometer comprises a two-dimensional accelerometer.
6. The accelerometer of claim 3, wherein the accelerometer comprises a three-dimensional accelerometer.
7. The sensing component of claim 1, wherein the sensing component comprises a transthoracic impedance sensor.
8. The sensing component of claim 1, wherein the sensing component comprises a cardio-activity sensor.
9. The sensing component of claim 1, wherein the sensing component comprises an oxygen saturation sensor.
10. The sensing component of claim 1, wherein the sensing component comprises a blood glucose sensor.
11. The sensing component of claim 1, wherein the sensing component comprises a cardiac output/ejection fraction sensor.
12. The sensing component of claim 1, wherein the sensing component comprises a chamber pressure sensor.
13. The sensing component of claim 1, wherein the sensing component comprises a temperature sensor.
14. The sensing component of claim 1, wherein the sensing component comprises a sodium sensor.
15. The sensing component of claim 1, wherein the sensing component comprises a potassium sensor.
16. The sensing component of claim 1, wherein the sensing component comprises a calcium sensor.
17. The sensing component of claim 1, wherein the sensing component comprises a magnesium sensor.
18. The sensing component of claim 1, wherein the sensing component comprises a pH sensor.
19. The sensing component of claim 1, wherein the sensing component comprises a partial oxygen sensor.
20. The sensing component of claim 1, wherein the sensing component comprises a partial CO2 sensor.
21. The sensing component of claim 1, wherein the sensing component comprises a cholesterol sensor.
22. The sensing component of claim 1, wherein the sensing component comprises a triglyceride sensor.
23. The sensing component of claim 1, wherein the sensing component comprises a catecholamine sensor.
24. The sensing component of claim 1, wherein the sensing component comprises a creatine phosphokinase sensor.
25. The sensing component of claim 1, wherein the sensing component comprises a lactate dehydrogenase sensor.
26. The sensing component of claim 1, wherein the sensing component comprises a troponin sensor.
27. The sensing component of claim 1, wherein the sensing component comprises a prothrombin time sensor.
28. The sensing component of claim 1, wherein the sensing component comprises a complete blood count sensor.
29. The sensing component of claim 1, wherein the sensing component comprises a blood urea nitrogen sensor.
30. The sensing component of claim 1, wherein the sensing component comprises a body weight sensor.
31. The sensing component of claim 1, wherein the sensing component comprises a blood (systemic) pressure sensor.
32. The sensing component of claim 1, wherein the sensing component comprises a adrenocorticotropic hormone sensor.
33. The sensing component of claim 1, wherein the sensing component comprises a thyroid marker sensor.
34. The sensing component of claim 1, wherein the sensing component comprises a gastric marker sensor.
35. The sensing component of claim 1, wherein the sensing component comprises a creatinine sensor.
36. The accelerometer of claim 3, wherein the accelerometer is adapted to sense the fine and gross body position of a person.
37. The fine and gross body position of claim 36, wherein the sensed body position of the person comprises standing, sitting, lying on the back, lying on the stomach, lying upon the left side and lying on the right side.
38. The accelerometer of claim 3, wherein the accelerometer is adapted to sense the fine and gross body motion of a person.
39. The fine and gross body motion of claim 38, wherein the sensed body motion comprises a baseline measurement of patient activity.
40. The fine and gross body motion of claim 38, wherein the sensed body motion comprises a measure of well-being.
41. The fine and gross body motion of claim 38, wherein the sensed body motion comprises a measure of lethargy.
42. The measure of lethargy of claim 41, wherein the measure comprises the magnitude of activity and the frequency of activity.
43. The accelerometer of claim 3, wherein the accelerometer is adapted to detect a cough.
44. The detected cough of claim 43, wherein the cough is analyzed to detect the onset of a common cold.
45. The detected cough of claim 43, wherein the cough is analyzed to detect the onset of influenza.
46. The detected cough of claim 43, wherein the cough is analyzed to titrate a drug.
47. The titrated drug of claim 46, wherein the drug is an angiotensin converting enzyme inhibitor.
48. The titrated drug of claim 46, wherein the drug comprises a near-term drug delivery system.
49. The near-term drug delivery system of claim 48, wherein the system comprises communication with a clinician.
50. The near-term drug delivery system of claim 48, wherein the system comprises communication with a patient.
51. The analysis component of claim 1, wherein the analysis is performed internal to the patient.
52. The analysis component of claim 1, wherein the analysis is performed external to the patient.
53. The analysis component of claim 1, wherein the analysis is performed, in part, internal to the patient.
54. The analysis component of claim 1, wherein the analysis is performed, in part, external to the patient.
55. The analysis component of claim 1, wherein the analysis includes detecting changes in sensed data patterns that are indicative of early occurrence of a new disease state.
56. The analysis component of claim 1, wherein the analysis includes detecting changes in sensed data patterns that are indicative of onset of illness.
57. The analysis component of claim 1, wherein the analysis includes detecting changes in sensed data patterns that are indicative of progression of a disease.
58. The analysis component of claim 1, wherein the analysis includes detecting changes in sensed accelerometer patterns that are indicative of early occurrence of a new disease state.
59. The analysis component of claim 1, wherein the analysis includes detecting changes in sensed accelerometer patterns that are indicative of onset of illness.
60. The analysis component of claim 1, wherein the analysis includes detecting changes in sensed accelerometer patterns that are indicative of progression of a disease.
61. The analysis component of claim 1, wherein the analysis includes detecting changes in transthoracic impedance variation patterns that are indicative of early occurrence of a new disease state.
62. The new disease state of claim 61, wherein the new disease state is chronic obstructive pulmonary disease.
63. The analysis component of claim 1, wherein the analysis includes detecting changes in transthoracic impedance variation patterns that are indicative of onset of illness.
64. The onset of illness of claim 63, wherein the illness comprises asthma.
65. The analysis component of claim 1, wherein the analysis includes detecting changes in transthoracic impedance variation patterns that indicate progression of a disease.
66. The progression of disease of claim 65, wherein the disease comprises heart failure.
67. The analysis component of claim 1, wherein the analysis includes combining sensed data to cross-validate sensed conclusions.
68. The combined sensed data of claim 67, wherein the combined data includes a change in accelerometer data pattern coincident with inhalation/exhalation time ratio measured by transthoracic impedance.
69. The combined data of claim 68, wherein the combined data indicates progression of asthma.
70. The analysis component of claim 1, wherein the analysis includes monitoring left and right intracardial R-wave amplitude.
71. The analysis of claim 70, wherein the analysis includes singly reporting changes.
72. The analysis of claim 71, wherein the analysis comprises an early and confident indication of onset of pulmonary edema.
73. The analysis of claim 70, wherein the analysis includes correlating left and right intracardial R-wave amplitude data with accelerometer and transthoracic impedance data.
74. The analysis of claim 73, wherein the analysis comprises an early and confident indication of onset of pulmonary edema.
75. The analysis component of claim 1, wherein the analysis includes combining accelerometer, transthoracic impedance and blood oxygen saturation data to form an early and confident indication of onset of pulmonary edema.
76. The analysis component of claim 1, wherein the analysis includes combining accelerometer, transthoracic impedance and blood oxygen saturation data to form an early and confident indication of progression of pulmonary edema.
77. The analysis component of claim 1, wherein the analysis includes combining accelerometer, transthoracic impedance, blood oxygen saturation, cardio-activity and blood glucose data for an early and confident indication of onset of cardiac and pulmonary disease states.
78. The analysis component of claim 1, wherein the analysis includes combining accelerometer, transthoracic impedance, blood oxygen saturation, cardio-activity and blood glucose data for an early and confident indication of changes in cardiac and pulmonary disease states.
79. The analysis component of claim 1, wherein the analysis includes combining data from other base sensors for an early and confident indication of onset of diseases other than cardio-pulmonary diseases.
80. The analysis component of claim 1, wherein the analysis includes combining data from other sensors for an early and confident indication of progression of diseases other than cardiopulmonary diseases.
81. The communications component of claim 1, wherein the communications are wired electronic communications.
82. The communications component of claim 1, wherein the communications are wireless electronic communications.
83. The communications component of claim 1, wherein the communications are a combination of wired and wireless electronic communications.
84. A method for predicting patient health and well-being within a patient management system comprising a medical device comprising the steps of:
a. sensing physiological function data with one or more sensor components in electronic communication with other components of the system and adapted to sense such data;
b. analyzing the sensed physiological data with an analysis component in electronic communication with other components of the system and adapted to analyze the sensed data; and
c. communicating the sensed and analyzed physiological data with a communications component in electronic communication with other components of the system and adapted to communicate the sensed and analyzed data to the components of the system.
85. The method of claim 84, wherein the step of sensing physiological function data comprises the further step of sensing a fine and gross body position of a person with an accelerometer.
86. The method of claim 84, wherein the step of sensing physiological function data comprises the further step of sensing respiration function data of a person with an transthoracic impedance sensor.
87. The method of claim 84, wherein the step of sensing physiological function data comprises the further step of sensing cardiac activity of a person with a cardio-activity sensor.
88. The method of claim 84, wherein the step of sensing physiological function data comprises the further step of oxygen saturation of a person with an oxygen saturation sensor.
89. The method of claim 84, wherein the step of sensing physiological function data comprises the further step of oxygen saturation of a person with a blood glucose sensor.
90. The method of claim 84, wherein the step of analyzing sensed physiological function data comprises the further step of analyzing changes in sensed data patterns that are indicative of early occurrence of a new disease state.
91. The method of claim 84, wherein the step of analyzing sensed physiological function data comprises the further step of analyzing changes in sensed data patterns that are indicative of onset of illness.
92. The method of claim 84, wherein the step of analyzing sensed physiological function data comprises the further step of analyzing changes in sensed data patterns that are indicative of progression of a disease.
93. The method of claim 84, wherein the step of analyzing sensed physiological function data comprises the further step of analyzing the sensed physiological function data by using clinically derived algorithms.
94. The step of analyzing sensed physiological function data of claim 93, wherein the step comprises the further step of analyzing the sensed physiological data by using algorithms reflecting a standard of medical care of a medical institution.
95. The method of claim 84, wherein the step of analyzing sensed physiological function data comprises the further step of analyzing the sensed physiological function data with an Advanced Patient Management system.
96. The method of claim 84, wherein the step of communicating the sensed and analyzed physiological function data comprises the further step of electronically communicating the sensed and analyzed data to other components of the system.
97. The method of claim 96, wherein the step of electronically communicating the sensed and analyzed physiological function data comprises the further step of wirelessly communicating the sensed and analyzed data.
98. The step of communicating the sensed and analyzed physiological function data of claim 96, wherein the step comprises the further step of communicating the sensed and analyzed data to a patient management system.
99. The step of communicating the sensed and analyzed physiological function data of claim 97, wherein the step comprises the further step of communicating the sensed and analyzed data to a patient management system.
100. The step of communicating the sensed and analyzed physiological function data of claim 96, wherein the step comprises the further step of communicating the sensed and analyzed data to an Advanced Patient Management system.
101. The step of communicating the sensed and analyzed physiological function data of claim 97, wherein the step comprises the further step of communicating the sensed and analyzed data to an Advanced Patient Management system.
Beschreibung
    TECHNICAL FIELD
  • [0001]
    The present system relates generally to a Patient Management System and particularly, but not by way of limitation, to such a system that can determine patient health, relative well-being and predictive degradation by using the sensing functions of an implantable medical device and analyzing the sensed patient data to predict patient health.
  • BACKGROUND
  • [0002]
    Implantable medical devices are becoming increasingly versatile and able to perform many different physiological sensing functions that enable a clinician to quickly and accurately assess patient health. Traditionally, an accurate assessment of patient health required the clinician to synthesize often divergent or seemingly unrelated indications of patient health. For example, a diagnosis of congestive heart failure might include not only an assessment and evaluation of cardiac function data, but also an evaluation of other physiological factors like patient fatigue or respiration data.
  • [0003]
    Typically, a clinician will assess patient health by inquiring how the patient feels or asking about the patient's activities and then make an indirect assessment based on the patient's response and the clinician's observation of the patient's appearance. However, these measures are very subjective and are limited to the time of the patient/clinician interaction and the quality of patient recall or willingness to divulge information. These factors affect the quality of the assessment.
  • [0004]
    Modern implantable medical devices offer objective data to help the clinician assess patient health. Modern medical devices can sense and analyze physiological factors with improved accuracy and report that sensed and analyzed information to the clinician or the patient. The data or information that a medical device reports in the form of a sensed physiological parameter can be characterized as either derived or non-derived data. Non-derived data can be understood as raw biometric information sensed by the medical device that has not been processed to any meaningful degree. For example, non-derived biometric information may comprise the quantified measurement of a patient's heart rate or blood pressure. In contrast, derived data is biometric information that has been analyzed and perhaps assigned some qualitative or quantitative value. For example, as a medical device senses a patient's cardiac cycle and clinically analyzes that information, the medical device may report that an arrhythmia has occurred as the result of sensing and analyzing a cardiac rhythm outside expected parameters. Other derived sensors may include, the cumulative calories burned by daily activity, a weight loss monitor, a participation in activities monitor, a depression monitor or determining the onset of cancer, all of which may be ascertained by sensing physiological data and analyzing that data by using clinically derived algorithms or other analytical tools.
  • [0005]
    An example of a sensor component of a medical device is an accelerometer. An accelerometer is essentially a device capable of measuring an object's relative orientation in a gravity field. It can directly sense patient movement (non-derived data) and present that information for analysis and perform as a derived sensor. Such derived information might include whether a patient is fatigued by reason of illness or because of overexertion. Thus, relative activity may correspond to relative patient health. In addition to simply determining whether a patient is ambulatory, a sensitive or finely-tuned accelerometer can also determine a patieht's relative position, i.e., whether the patient is sitting, standing, sleeping or distinguish whether the patient is prone because he decided to lie down instead of abruptly falling down. A sensitive accelerometer can also detect fine body movement, like the physical reflexes of a person coughing or sneezing.
  • [0006]
    Coughing is often more than an indication of a respiratory irritation or condition like asthma or the onset of the common cold, but may also be a common side effect of certain drugs. For example, Angiotensin Converting Enzyme (“ACE”) inhibitors may cause a patient to cough when the patient's dosage is too high. Thus, coughing may be used to titrate the appropriate dose of a drug like an ACE inhibitor.
  • [0007]
    Implantable medical devices comprising cardio-sensors, i.e., pacemakers, can also monitor and sense a patient's cardiac activity and provide remedial therapy. In addition, such medical devices can sense and measure transthoracic impedance as a means to evaluate patient respiration data.
  • [0008]
    As a measurement of respiration, modern implantable medical devices often employ a sensor that measures transthoracic impedance. Transthoracic impedance is essentially the measure of a voltage across some known spacing or distance. To measure this voltage, the medical device drives a current from the device to the tip of a lead and voltage is measured from another area proximate to the device and another area proximate to the lead. For example, as a person's heart pumps, the transthoracic impedance changes because the heart is moving relative to the implanted device. Similarly, as a person's lung inflates and deflates as he breathes, the geometry of the current flowing between the device and the tip of the lead changes. In measuring respiration, the spacing or distance is situated in such a way that the distance crosses over either a person's left or right lung. Thus, when the geometry changes, the resistance also changes. In the context of breathing, the periodicity of the resistance also can serve as an indication of the relative depth or shallowness of breathing. In other words, a transthoracic impedance sensor can determine the symmetrical relationship between inhalation and exhalation. The symmetry of inhalation to exhalation can establish a pattern of respiration that may have clinical meaning, like determining asthma, apnea or chronic obstructive pulmonary disease (“COPD”). Within the context of detecting an asthma attack, a symmetrical breathing pattern recognized by a transthoracic impedance monitor may comprise the forced expiratory volume over one second (“FEV1”). Modern medical devices that measure transthoracic impedance can be configured to filter out the cardiac component and other impedance noise and concentrate on measuring the breathing component.
  • [0009]
    An implantable medical device may also employ a sensor that measures blood glucose levels. In this way, the medical device may predict the need for insulin therapy before the patient or clinician observes acute symptoms of hyperglycemia.
  • [0010]
    However, the data sensed by modern implantable medical devices is often presented in a form that merely reduces the data to some numerical or relative value that requires the clinician to further analyze the numerical or relative value output to make a meaningful clinical assessment. In addition, current implantable medical devices frequently are not analytically robust enough to provide meaningful diagnostic assessments or predictions of patient health beyond the mere reporting of physiological data. Merely reporting physiological data can be of limited value due to a person's natural ability to initially compensate for nascent changes in health status. Because of such analytical and perceptual limitations, sensing cardiac activity or transthoracic impedance data through a single implantable medical device may only provide the clinician with a useful starting point for further clinical analysis.
  • [0011]
    Thus, for these and other reasons, there is a need for a Patient Management System comprising an implantable medical device further comprising various physiological sensors that sense and report patient data. The system is further adapted to analyze the sensed data in a manner that yields an accurate assessment or prediction of patient health or relative well-being. In this way, the system can be configured to not only report a relative state of patient health and detect early stage disease progression, but also alert the clinician to patient health degradation before the onset of an acute episode or symptomatic illness.
  • SUMMARY
  • [0012]
    According to one aspect of the invention, there is provided a system and method for predicting patient health and relative well-being within a Patient Management System using an implantable medical device configured with multiple physiological sensors in communication with other components of the system via a communications network.
  • [0013]
    The Patient Management System further includes an analytical component contained within the medical device or outside the device or a combination of internal and external analytical components. A non-limiting example of such an analytical component is an externally-based Advanced Patient Management System. As used herein, “physiological function data,” “physiology data,” “patient data” and “patient health data” are substantively synonymous terms and relate to a measurable or relative physiological parameter. In addition to physical parameters like heart rate, respiration and blood chemistry, physiological parameters may include, for example, subjective evaluations of well-being, perceived emotional state and other psychological attributes. Also, as used herein, a “clinician” can be a physician, physician assistant (PA), nurse, medical technologist, or any other patient health care provider.
  • [0014]
    In one embodiment of a system for predicting patient health and relative well-being within a patient management system, the system comprises a medical device further comprising a sensing component, an analysis component and a communications component. The sensing component includes one or more base sensors adapted to sense physiological function data. The analysis component is adapted to analyze physiological data sensed by the sensing component and detect subtle, early indications of changes in disease state. The communications component is adapted to communicate sensed and analyzed physiological data to the components of the system.
  • [0015]
    In another embodiment of the system for predicting patient health and relative well-being within a patient management system, the medical device comprising sensing, analysis and communications components is implanted within a patient, and the sensing component includes an accelerometer. The accelerometer can be configured to detect a patient's fine and gross body motion, and can be a one-, two- or three-dimensional accelerometer. Example analysis includes detecting changes in measured accelerometer patterns that are indicative of early occurrence of a new disease state or onset of illness or indicate progression of a disease.
  • [0016]
    In a further embodiment of the system for predicting patient health and relative well-being within a patient management system, the sensing component of the implantable medical device comprises an accelerometer and a transthoracic impedance sensor. In this embodiment, the implantable medical device is adapted to detect a patient's fine and gross body motion and respiration parameters. Example analysis includes detecting changes in transthoracic impedance variation patterns that are indicative of early occurrence of a new disease state (such as COPD) or onset of illness (such as asthma) or indicate progression of a disease (such as DC impedance indicating lung fluid accumulation which corresponds to progression of heart failure). Further, the sensed data can be used in combination to cross-validate sensed conclusions, such as a change in accelerometer data pattern coincident with inhalation/exhalation time ratio measured by transthoracic impedance to indicate progression of asthma.
  • [0017]
    In yet another embodiment of the system for predicting patient health and relative well-being within a patient management system, the sensing component of the implantable medical device comprises an accelerometer, a transthoracic impedance sensor and a cardio-activity sensor. In this embodiment, the implantable medical device is adapted to detect a patient's fine and gross body motion, respiration parameters, and cardiac-activity parameters. Example analysis includes monitoring left and right intracardial R-wave amplitude and either singly reporting changes or correlating changes with changes in accelerometer and transthoracic impedance to form an early and confident indication of onset of pulmonary edema.
  • [0018]
    In yet a further embodiment of the system for predicting patient health and relative well-being within a patient management system, the sensing component of the implantable medical device comprises an accelerometer, a transthoracic impedance sensor, and an oxygen saturation sensor. In this embodiment, the implantable medical device is adapted to detect a patient's fine and gross body motion, respiration parameters, cardiac-activity parameters and blood gas data. Example analysis includes combining changes in accelerometer and transthoracic impedance with blood oxygen saturation to form an early and confident indication of onset or progression of pulmonary edema.
  • [0019]
    In a preferred embodiment of the system for predicting patient health and relative well-being within a patient management system, the sensing component of the implantable medical device comprises a three-dimensional accelerometer, a transthoracic impedance sensor, a cardio-activity sensor, an oxygen saturation sensor and a blood glucose sensor. In this embodiment, the implantable medical device is adapted to detect a patient's fine and gross body motion, respiration parameters, cardiac-activity parameters, blood gas data and episodes of hyper- and hypoglycemia. Example analysis includes combining changes in accelerometer data, transthoracic impedance, blood oxygen saturation, cardio-activity and blood glucose for an early and confident indication of onset and changes in cardiac and pulmonary disease states.
  • [0020]
    By selecting other base sensors, early and confident indications of onset or progression of diseases beyond cardiopulmonary can be made. By way of non-limiting example only, other base sensors might include a cardiac output/ejection fraction sensor; a chamber pressure sensor; a temperature sensor; sodium, potassium, calcium and magnesium sensors; a pH sensor; a partial oxygen sensor; a partial CO2 sensor; a cholesterol and triglyceride sensor; a catecholamine sensor; a creatine phosphokinase sensor; a lactate dehydrogenase sensor; a troponin sensor; a prothrombin time sensor; a complete blood count sensor; a blood urea nitrogen sensor; a body weight sensor; a blood (systemic) pressure sensor; a adrenocorticotropic hormone sensor; a thyroid marker sensor; a gastric marker sensor and a creatinine sensor. Data from these sensors can be analyzed to predict or detect, by way of non-limiting example only, the early onset of stroke, pain quantification/determination, chronic depression, cancer tissue (onset, progression, recurrence), syncope, autonomic tone, myocardial infarct, ischemia and seizure.
  • [0021]
    The various embodiments described above are provided by way of illustration only and should not be construed to limit the invention. Those skilled in the art will readily recognize various modifications and changes that may be made to the present invention without following the example embodiments and applications illustrated and described herein, and without departing from the true spirit and scope of the present invention, which is set forth in the following claims.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0022]
    In the drawings, which are not necessarily drawn to scale, like numerals describe substantially similar components throughout the several views. Like numerals having different letter suffixes represent different instances of substantially similar components. The drawings illustrate generally, by way of example, but not by way of limitation, various embodiments discussed in the present document.
  • [0023]
    [0023]FIG. 1 is a schematic/block diagram illustrating generally, among other things, one embodiment of the system and method for predicting patient health within a patient management system.
  • [0024]
    [0024]FIG. 2 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within a patient management system comprising an accelerometer.
  • [0025]
    [0025]FIG. 3 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within a patient management system comprising an accelerometer and a transthoracic impedance sensor.
  • [0026]
    [0026]FIG. 4 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within a patient management system comprising an accelerometer, a transthoracic impedance sensor and an oxygen saturation sensor.
  • [0027]
    [0027]FIG. 5 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within a patient management system comprising an accelerometer, a transthoracic impedance sensor, an oxygen saturation sensor and a cardio-activity sensor.
  • [0028]
    [0028]FIG. 6 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within a patient management system comprising an accelerometer, a transthoracic impedance sensor, an oxygen saturation sensor, a cardio-activity sensor and a blood glucose sensor.
  • [0029]
    [0029]FIG. 7 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within an Advanced Patient Management system.
  • [0030]
    [0030]FIG. 8 is a flow diagram illustrating generally, among other things, the interactive functions of the system and method for predicting patient health within a patient management system.
  • DETAILED DESCRIPTION
  • [0031]
    In the following detailed description, reference is made to the accompanying drawings that form a part hereof, and in which are shown by way of illustration, specific embodiments or examples. These embodiments may be combined, other embodiments may be utilized, and structural, logical and electrical changes may be made without departing from the spirit and scope of the present invention. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims and their equivalents.
  • [0032]
    The present system and method are described with respect to an implantable medical device as a component of a Patient Management System capable of predicting patient health and relative well-being by the comprehensively analyzing sensed physiological data.
  • [0033]
    [0033]FIG. 1 is a schematic/block diagram illustrating generally an embodiment of the system and method for predicting patient health and relative well-being within a patient management system 100. The system comprises a medical device further comprising a sensing component 101, an analysis component 102 and a communications component 103. The medical device can be implantable 104 within a patient 105.
  • [0034]
    The sensing component 101 includes one or more sensors adapted to sense physiological data. The sensors may comprise an accelerometer, a transthoracic impedance sensor, an oxygen saturation sensor, and a cardio-activity sensor.
  • [0035]
    The analysis component 102 is adapted to analyze physiological data sensed by the sensing component. Analysis may be internal and/or external to the patient. Analysis may include the use of clinically derived algorithms to analyze the biometric data in a way that yields a clinically relevant output. The algorithms can be the result of the extraction, codification and use of collected expert knowledge for the analysis or diagnosis of medical conditions. For example, the algorithms can comprise institutional analytical or diagnostic techniques used in specific clinical settings. By reducing the analytical or diagnostic methodologies of institutions like the Cleveland Clinic, the Mayo Clinic or the Kaiser Permanente system to algorithmic expression, a patient will enjoy the benefit of the medical expertise of a leading medical institution without having to visit the institution. The analysis and sensing components are further adapted to electronically communicate with the communications component.
  • [0036]
    The communications component 103 is adapted to communicate sensed and analyzed physiological data to the components of the system, whether the components are internal or external to the patient.
  • [0037]
    [0037]FIG. 2 is a schematic/block diagram illustrating generally an embodiment of the accelerometer 200 component of the system and method for predicting patient health and relative well-being within a patient management system. The accelerometer 200 can be configured to detect a patient's fine and gross body motion. A suitable accelerometer includes a one-dimensional, two-dimensional 200 or three-dimensional accelerometer. Typically, a one-dimensional accelerometer only measures movement along a single axis 201 as further illustrated in FIG. 2. A two-dimensional accelerometer typically measures movement along two orthogonal axes 202. A three-dimensional accelerometer measures movement along three orthogonal axes 203. When the system comprises a three-dimensional accelerometer, the system can determine person's body position with greatest accuracy. Thus, in addition to detecting gross body movement, a sensitive accelerometer may be adapted to detect fine body movement, like a person coughing. When the system is configured to analyze accelerometer data to determine whether a person is coughing, a clinician can utilize that derivative information two assist in determining the onset of a common cold, influenza or the proper dosage of a drug, like an ACE inhibitor, that may cause a coughing side effect when the dosage is too high. In addition, coughing or other activity sensed by the accelerometer 200 may be used to titrate the dosage of other drugs as a component of a near-term drug delivery system, wherein the titration analysis is communicated to the patient or the clinician.
  • [0038]
    [0038]FIG. 3 is a schematic/block diagram illustrating generally an embodiment of the transthoracic impedance sensor 300 component of the system and method for predicting patient health and relative well-being within a patient management system. In one embodiment, as illustrated in FIG. 3, the transthoracic impedance sensor 300 is a component of an implantable medical device 301. In this embodiment, the implantable medical device comprises an accelerometer 200 as illustrated in FIG. 2 and a transthoracic impedance sensor 300. A transthoracic impedance sensor 300 may be adapted to sense impedance changes in the heart or lungs or both. The transthoracic impedance sensor can be configured to filter out the cardiac component and other impedance noise and focus on respiration measurement. In such a filtered embodiment, the transthoracic impedance sensor 300 can assist the clinician in predicting the onset or presence of an asthma attack, apnea, COPD and FEV1. Further, in this embodiment, the transthoracic impedance sensor 300 may also be configured to detect the accumulation of fluid in the lungs. Such detection may also serve to predictively indicate the onset or existence of pulmonary disease.
  • [0039]
    [0039]FIG. 4 is a schematic/block diagram illustrating generally an embodiment of the oxygen saturation sensor 400 component of the system and method for predicting patient health and relative well-being within a patient management system. In one embodiment, as illustrated in FIG. 4, the oxygen saturation sensor 400 is a component of an implantable medical device 301. In this embodiment, the implantable medical device comprises an accelerometer 200 as illustrated in FIG. 2, a transthoracic impedance sensor 300 and an oxygen saturation sensor 400. An oxygen saturation sensor 400 determines the ratio between the deoxygenated hemoglobin and oxygenated hemoglobin. In a healthy person, breathing air at sea level, the level of saturation is between 96% and, 98%. Abnormal levels may indicate a respiratory or environmental problem. When combined with other measurements of patient health, a patient's oxygen saturation level may provide further evidence of patient health or relative well-being.
  • [0040]
    [0040]FIG. 5 is a schematic/block diagram illustrating generally an embodiment of the cardio-activity sensor 500 component of the system and method for predicting patient health and relative well-being within a patient management system. In one embodiment, as illustrated in FIG. 5, the cardio-activity sensor 500 is a component of an implantable medical device 301. In this embodiment, the implantable medical device comprises an accelerometer 200 as illustrated in FIG. 2, a transthoracic impedance sensor 300, an oxygen saturation sensor 400, and a cardio-activity sensor 500. The cardio-activity sensor 500 may be configured to detect cardiac arrhythmias. Depending on the nature of the arrhythmia, the cardio-activity sensor 500 may cause therapy to be directed to the patient in the form of a low energy electrical stimuli, i.e., pace pulse, or a defibrillation countershock. The cardio-activity sensor 500 may also be used to signal a clinician that an arrhythmia requires further analysis or medical intervention. The cardio-activity sensor 500 in this embodiment may also assist in predicting stroke by measuring ST-segment changes in an electrocardiogram and conveying that information to the analysis component 102 to confirm ST-segment elevations or abnormalities.
  • [0041]
    [0041]FIG. 6 is a schematic/block diagram illustrating generally an embodiment of the blood glucose sensor 600 component of the system and method for predicting patient health and relative well-being within a patient management system. In one embodiment, as illustrated in FIG. 6, the blood glucose sensor 600 is a component of an implantable medical device 301. In this embodiment, the implantable medical device comprises an accelerometer 200 as illustrated in FIG. 2, a transthoracic impedance sensor 300, an oxygen saturation sensor 400, a cardio-activity sensor 500 and a blood glucose sensor 600. The blood glucose sensor 600 may be configured to detect elevations or de-elevations in blood glucose. Depending on the nature of the blood glucose level, the blood glucose sensor 600 may cause therapy to be directed to the patient in the form of insulin administration or be used to signal an alert to the patient or clinician.
  • [0042]
    [0042]FIG. 7 is a schematic/block diagram illustrating generally an embodiment of the system and method for predicting patient health and relative well-being within a patient management system 100 illustrating the analysis of patient data by an externally-based Advanced Patient Management System (“APM”) 700.
  • [0043]
    APM is a system that helps patients, their physicians and their families to better monitor, predict and manage chronic diseases. In the embodiment shown in FIG. 7, the APM system 700 consists of three primary components: 1) an implantable medical device 301 with sensors adapted to monitor physiological data, 2) a Data Management System (“DMS”) 701, adapted to process and store patient data 701 a collected from the sensors, patient population data 701 b, medical practice data 601 c further comprising clinically derived algorithms, and general practice data 701 d, and 3) an analytical engine 702 adapted to analyze data from the DMS. APM is designed to support physicians and other clinicians in using a variety of different devices, patient-specific and non-specific data, along with medication therapy, to provide the best possible care to patients. Currently, implanted devices often provide only limited sensing, analysis and therapy to patients. APM moves the device from a reactive mode into a predictive one that allows a clinician to use APM to predict patient health.
  • [0044]
    [0044]FIG. 8 is a flow diagram illustrating generally the interactive functions of the system and method for predicting patient health and relative well-being within a patient management system 100. As illustrated in FIG. 8, the sensing 800, analysis 701 and communications 802 components are interactive, thus allowing the components to communicate and share data. By way of non-limiting example only, the sensing component 800 would first sense physiological function data from a patient 105. The sensing component 800 may be further adapted to provide therapy to the patient 105. That data would then be transmitted to analysis component 801 for analysis. Analysis may comprise the use of clinically derived algorithms and may be performed internal and/or external to the patient 105. Based on the analysis, the sensing component 800 may be further adapted to provide therapy to the patient 105. The analyzed data is then received by communications module 802, which reports the analyzed data in the form of a determination of patient health or relative well-being to a patient 105 or clinician 105 a. The communications component 802 may also be in communication with a patient management system, including an externally based Advanced Patient Management system 803. Communication can be in the form of wired or wireless electronic communication.
  • [0045]
    The various embodiments described above are provided by way of illustration only and should not be construed to limit the invention. Those skilled in the art will readily recognize various modifications and changes that may be made to the present invention without following the example embodiments and applications illustrated and described herein, and without departing from the true spirit and scope of the present invention, which is set forth in the following claims.
  • [0046]
    It is to be understood that the above description is intended to be illustrative, and not restrictive. For example, the above-described embodiments may be used in combination with each other. Many other embodiments will be apparent to those of skill in the art upon reviewing the above description. The scope of the invention should, therefore, be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled. In the appended claims, the terms “including,” “includes” and “in which” are used as the plain-English equivalents of the respective terms “comprising,” “comprises” and “wherein.”
Patentzitate
Zitiertes PatentEingetragen Veröffentlichungsdatum Antragsteller Titel
US4706689 *8. Jan. 198717. Nov. 1987Daniel ManImplantable homing device
US4750494 *24. Juni 198714. Juni 1988Medtronic, Inc.Automatic implantable fibrillation preventer
US5116759 *27. Juni 199026. Mai 1992Fiberchem Inc.Reservoir chemical sensors
US5331966 *16. Dez. 199326. Juli 1994Medtronic, Inc.Subcutaneous multi-electrode sensing system, method and pacer
US5629678 *10. Jan. 199513. Mai 1997Paul A. GarganoPersonal tracking and recovery system
US6104949 *9. Sept. 199815. Aug. 2000Vitatron Medical, B.V.Medical device
US6398728 *16. Nov. 19994. Juni 2002Cardiac Intelligence CorporationAutomated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof
US6595927 *23. Juli 200122. Juli 2003Medtronic, Inc.Method and system for diagnosing and administering therapy of pulmonary congestion
US6997879 *9. Juli 200214. Febr. 2006Pacesetter, Inc.Methods and devices for reduction of motion-induced noise in optical vascular plethysmography
US20040140209 *30. Mai 200222. Juli 2004Moon-Hee ChoiBiosensor
Referenziert von
Zitiert von PatentEingetragen Veröffentlichungsdatum Antragsteller Titel
US707781031. Jan. 200518. Juli 2006Earlysense Ltd.Techniques for prediction and monitoring of respiration-manifested clinical episodes
US73144513. Aug. 20051. Jan. 2008Earlysense Ltd.Techniques for prediction and monitoring of clinical episodes
US7396333 *18. Aug. 20038. Juli 2008Cardiac Pacemakers, Inc.Prediction of disordered breathing
US7507203 *21. Sept. 200524. März 2009Digital Signal CorporationSystem and method for remotely monitoring physiological functions
US751182414. Febr. 200631. März 2009Digital Signal CorporationChirped coherent laser radar system and method
US7630755 *4. Mai 20058. Dez. 2009Cardiac Pacemakers Inc.Syncope logbook and method of using same
US766210131. Aug. 200416. Febr. 2010Cardiac Pacemakers, Inc.Therapy control based on cardiopulmonary status
US766454615. Sept. 200416. Febr. 2010Cardiac Pacemakers, Inc.Posture detection system and method
US766859120. Aug. 200423. Febr. 2010Cardiac Pacemakers, Inc.Automatic activation of medical processes
US767271816. Juni 20082. März 2010Cardiac Pacemakers, Inc.Thoracic impedance detection with blood resistivity compensation
US768053718. Aug. 200316. März 2010Cardiac Pacemakers, Inc.Therapy triggered by prediction of disordered breathing
US769946914. Dez. 200620. Apr. 2010Digital Signal CorporationSystem and method for tracking eyeball motion
US772054118. Aug. 200318. Mai 2010Cardiac Pacemakers, Inc.Adaptive therapy for disordered breathing
US77473238. Juni 200429. Juni 2010Cardiac Pacemakers, Inc.Adaptive baroreflex stimulation therapy for disordered breathing
US775769013. Sept. 200420. Juli 2010Cardiac Pacemakers, Inc.System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep
US77668401. Dez. 20053. Aug. 2010Cardiac Pacemakers, Inc.Method and system for heart failure status evaluation based on a disordered breathing index
US77668426. Aug. 20073. Aug. 2010Cardiac Pacemakers, Inc.Detection of disordered breathing
US777598316. Sept. 200517. Aug. 2010Cardiac Pacemakers, Inc.Rapid shallow breathing detection for use in congestive heart failure status determination
US778794617. Sept. 200431. Aug. 2010Cardiac Pacemakers, Inc.Patient monitoring, diagnosis, and/or therapy systems and methods
US780944117. Mai 20065. Okt. 2010Cardiac Pacemakers, Inc.Implantable medical device with chemical sensor and related methods
US781981629. März 200626. Okt. 2010Cardiac Pacemakers, Inc.Periodic disordered breathing detection
US786987710. Sept. 200711. Jan. 2011Cardiac Pacemakers, Inc.Cardiopulmonary functional status assessment via heart rate response detection by implantable cardiac device
US78817811. Dez. 20091. Febr. 2011Cardiac Pacemakers, Inc.Thoracic impedance detection with blood resistivity compensation
US788749313. Sept. 200415. Febr. 2011Cardiac Pacemakers, Inc.Implantable device employing movement sensing for detecting sleep-related disorders
US7899508 *10. März 20051. März 2011Board Of Regents, The University Of Texas SystemIntracorporeal impedance and leak monitoring device
US790799711. Mai 200515. März 2011Cardiac Pacemakers, Inc.Enhancements to the detection of pulmonary edema when using transthoracic impedance
US792027226. Febr. 20095. Apr. 2011Digital Signal CorporationChirped coherent laser radar system and method
US793160021. Aug. 200926. Apr. 2011Cardiac Pacemakers, Inc.Apparatus and method for detecting lung sounds using an implanted device
US7938782 *12. Mai 200810. Mai 2011Cardiac Pacemakers, Inc.Prediction of disordered breathing
US796775615. Sept. 200428. Juni 2011Cardiac Pacemakers, Inc.Respiratory therapy control based on cardiac cycle
US797047030. Aug. 200428. Juni 2011Cardiac Pacemakers, Inc.Diagnosis and/or therapy using blood chemistry/expired gas parameter analysis
US797911510. Jan. 200812. Juli 2011Cardiac Pacemakers, Inc.Detection of pleural effusion using transthoracic impedance
US799328030. Juli 20109. Aug. 2011Cardiac Pacemakers, Inc.Rapid shallow breathing detection for use in congestive heart failure status determination
US799868324. Apr. 200716. Aug. 2011Critical Care Diagnostics, Inc.Predicting mortality and detecting severe disease
US800255318. Aug. 200323. Aug. 2011Cardiac Pacemakers, Inc.Sleep quality data collection and evaluation
US8066640 *21. Apr. 200929. Nov. 2011EOS Health, Inc.Cellular GPRS-communication linked glucometer—pedometer
US808167014. Febr. 200620. Dez. 2011Digital Signal CorporationSystem and method for providing chirped electromagnetic radiation
US809056217. Apr. 20093. Jan. 2012Critical Care Diagnostics, Inc.Predicting risk of major adverse cardiac events
US810447021. Aug. 200931. Jan. 2012Cardiac Pacemakers, Inc.Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US811684112. Sept. 200814. Febr. 2012Corventis, Inc.Adherent device with multiple physiological sensors
US811686916. Juni 200814. Febr. 2012Cardiac Pacemakers, Inc.Cardiopulmonary functional status assessment via metabolic response detection by implantable cardiac device
US812655417. Mai 200628. Febr. 2012Cardiac Pacemakers, Inc.Implantable medical device with chemical sensor and related methods
US817736319. Apr. 201015. Mai 2012Digital Signal CorporationSystem and method for tracking eyeball motion
US820032120. Mai 200912. Juni 2012Sotera Wireless, Inc.Method for measuring patient posture and vital signs
US820032610. Sept. 200912. Juni 2012Cardiac Pacemakers, Inc.Calibration of impedance monitoring of respiratory volumes using thoracic D.C. impedance
US822132715. Jan. 201017. Juli 2012Cardiac Pacemakers, Inc.Therapy control based on cardiopulmonary status
US824968612. Sept. 200821. Aug. 2012Corventis, Inc.Adherent device for sleep disordered breathing
US825106130. Aug. 200428. Aug. 2012Cardiac Pacemakers, Inc.Methods and systems for control of gas therapy
US828535610. Jan. 20129. Okt. 2012Corventis, Inc.Adherent device with multiple physiological sensors
US831771926. Apr. 201127. Nov. 2012Cardiac Pacemakers, Inc.Apparatus and method for detecting lung sounds using an implanted device
US832100415. Sept. 200927. Nov. 2012Sotera Wireless, Inc.Body-worn vital sign monitor
US832102224. März 201027. Nov. 2012Cardiac Pacemakers, Inc.Adaptive therapy for disordered breathing
US832320413. März 20094. Dez. 2012Cardiac Pacemakers, Inc.Medical event logbook system and method
US836425015. Sept. 200929. Jan. 2013Sotera Wireless, Inc.Body-worn vital sign monitor
US837468812. Sept. 200812. Febr. 2013Corventis, Inc.System and methods for wireless body fluid monitoring
US83769542. Juni 200619. Febr. 2013Earlysense Ltd.Techniques for prediction and monitoring of respiration-manifested clinical episodes
US838029630. Dez. 200919. Febr. 2013Cardiac Pacemakers, Inc.Automatic activation of medical processes
US8403865 *25. Juli 200726. März 2013Earlysense Ltd.Prediction and monitoring of clinical episodes
US841231720. Apr. 20092. Apr. 2013Corventis, Inc.Method and apparatus to measure bioelectric impedance of patient tissue
US843782414. Sept. 20097. Mai 2013Sotera Wireless, Inc.Body-worn pulse oximeter
US844263817. Mai 201014. Mai 2013Cardiac Pacemakers, Inc.Adaptive baroreflex stimulation therapy for disordered breathing
US846018912. Sept. 200811. Juni 2013Corventis, Inc.Adherent cardiac monitor with advanced sensing capabilities
US847537020. Mai 20092. Juli 2013Sotera Wireless, Inc.Method for measuring patient motion, activity level, and posture along with PTT-based blood pressure
US847537131. Aug. 20102. Juli 2013Adidas AgPhysiological monitoring garment
US847538830. Juli 20102. Juli 2013Cardiac Pacemakers, Inc.Detection of disordered breathing
US848381823. Febr. 20119. Juli 2013Cardiac Pacemakers, Inc.Enhancements to the detection of pulmonary edema when using transthoracic impedance
US849149213. Mai 201123. Juli 2013Earlysense Ltd.Monitoring a condition of a subject
US84965965. Febr. 201030. Juli 2013Cardiac Pacemakers, Inc.Systems and methods for determining respiration metrics
US851553528. Jan. 201020. Aug. 2013Cardiac Pacemakers, Inc.Implantable cardiac device with dyspnea measurement
US851795323. Juli 201027. Aug. 2013Earlysense Ltd.Techniques for prediction and monitoring of coughing-manifested clinical episodes
US852277931. Jan. 20123. Sept. 2013Cardiac Pacemakers, Inc.Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US852703815. Sept. 20093. Sept. 2013Sotera Wireless, Inc.Body-worn vital sign monitor
US85301731. Juni 201110. Sept. 2013The Brigham And Women's Hospital, Inc.Methods for treatment of cardiovascular disease
US8533007 *5. Dez. 200610. Sept. 2013Koninklijke Philips N.V.Chronic illness goal management
US853522213. März 200717. Sept. 2013Cardiac Pacemakers, Inc.Sleep detection using an adjustable threshold
US853852513. Febr. 201217. Sept. 2013Cardiac Pacemakers, Inc.Cardiopulmonary functional status assessment via metabolic response detection by implantable cardiac device
US854541714. Sept. 20091. Okt. 2013Sotera Wireless, Inc.Body-worn monitor for measuring respiration rate
US855429714. Sept. 20098. Okt. 2013Sotera Wireless, Inc.Body-worn pulse oximeter
US857165927. Jan. 201229. Okt. 2013Cardiac Pacemakers, Inc.Implantable medical device with chemical sensor and related methods
US857943914. Mai 201212. Nov. 2013Digital Signal CorporationSystem and method for tracking eyeball motion
US85820854. Apr. 201112. Nov. 2013Digital Signal CorporationChirped coherent laser radar with multiple simultaneous measurements
US85856073. Nov. 201019. Nov. 2013Earlysense Ltd.Monitoring, predicting and treating clinical episodes
US859141119. Apr. 201026. Nov. 2013Sotera Wireless, Inc.Body-worn vital sign monitor
US859143012. Sept. 200826. Nov. 2013Corventis, Inc.Adherent device for respiratory monitoring
US859477628. März 201226. Nov. 2013Sotera Wireless, Inc.Alarm system that processes both motion and vital signs using specific heuristic rules and thresholds
US86005025. Juni 20123. Dez. 2013Cardiac Pacemakers, Inc.Sleep state classification
US860299730. Dez. 200910. Dez. 2013Sotera Wireless, Inc.Body-worn system for measuring continuous non-invasive blood pressure (cNIBP)
US860301025. Jan. 201310. Dez. 2013Earlysense Ltd.Techniques for prediction and monitoring of clinical episodes
US860635617. Aug. 200410. Dez. 2013Cardiac Pacemakers, Inc.Autonomic arousal detection system and method
US86178258. Juli 201131. Dez. 2013Critical Care Diagnostics, Inc.Predicting mortality and detecting severe disease
US862292214. Sept. 20097. Jan. 2014Sotera Wireless, Inc.Body-worn monitor for measuring respiration rate
US865775615. Febr. 201125. Febr. 2014Cardiac Pacemakers, Inc.Implantable device employing movement sensing for detecting sleep-related disorders
US866063811. Nov. 200925. Febr. 2014Cardiac Pacemakers, Inc.Syncope logbook and method of using same
US867285420. Mai 200918. März 2014Sotera Wireless, Inc.System for calibrating a PTT-based blood pressure measurement using arm height
US867903019. Juni 201325. März 2014Earlysense Ltd.Monitoring a condition of a subject
US868492512. Sept. 20081. Apr. 2014Corventis, Inc.Injectable device for physiological monitoring
US869658930. Juli 201015. Apr. 2014Cardiac Pacemakers, Inc.Method and system for heart failure status evaluation based on a disordered breathing index
US871754522. Febr. 20106. Mai 2014Digital Signal CorporationSystem and method for generating three dimensional images using lidar and video measurements
US871875211. März 20096. Mai 2014Corventis, Inc.Heart failure decompensation prediction based on cardiac rhythm
US872797719. Apr. 201020. Mai 2014Sotera Wireless, Inc.Body-worn vital sign monitor
US872874216. März 201220. Mai 2014Critical Care Diagnostics, Inc.Methods predicting risk of an adverse clinical outcome
US87316466. Sept. 201320. Mai 2014Earlysense Ltd.Prediction and monitoring of clinical episodes
US873436015. Okt. 201327. Mai 2014Earlysense Ltd.Monitoring, predicting and treating clinical episodes
US87347698. März 201327. Mai 2014The Brigham And Women's Hospital, Inc.1L1RL-1 as a cardiovascular disease marker and therapeutic target
US873811820. Mai 200927. Mai 2014Sotera Wireless, Inc.Cable system for generating signals for detecting motion and measuring vital signs
US874080230. Dez. 20093. Juni 2014Sotera Wireless, Inc.Body-worn system for measuring continuous non-invasive blood pressure (cNIBP)
US874080714. Sept. 20093. Juni 2014Sotera Wireless, Inc.Body-worn monitor for measuring respiration rate
US874733019. Apr. 201010. Juni 2014Sotera Wireless, Inc.Body-worn monitor for measuring respiratory rate
US87481167. März 201310. Juni 2014The Brigham And Women's Hospital, Inc.1L1RL-1 as a cardiovascular disease marker and therapeutic target
US875099215. Aug. 201310. Juni 2014Cardiac Pacemakers, Inc.Implantable cardiac device with dyspnea measurement
US879025712. Sept. 200829. Juli 2014Corventis, Inc.Multi-sensor patient monitor to detect impending cardiac decompensation
US879025922. Okt. 201029. Juli 2014Corventis, Inc.Method and apparatus for remote detection and monitoring of functional chronotropic incompetence
US8795189 *11. Febr. 20085. Aug. 2014Cardiac Pacemakers, Inc.System and method for determining pulmonary performance from transthoracic impedance measures
US880818830. Dez. 200919. Aug. 2014Sotera Wireless, Inc.Body-worn system for measuring continuous non-invasive blood pressure (cNIBP)
US882141810. Mai 20092. Sept. 2014Earlysense Ltd.Monitoring, predicting and treating clinical episodes
US88405648. Jan. 201423. Sept. 2014Early Sense Ltd.Monitoring a condition of a subject
US884332126. Jan. 201023. Sept. 2014Roche Diagnostics Operations, Inc.Methods and systems for processing glucose data measured from a person having diabetes
US88714527. März 201328. Okt. 2014The Brigham And Women's Hospital, Inc.Methods for treatment of cardiovascular disease
US888268430. Mai 201311. Nov. 2014Earlysense Ltd.Monitoring, predicting and treating clinical episodes
US888870019. Apr. 201018. Nov. 2014Sotera Wireless, Inc.Body-worn monitor for measuring respiratory rate
US889156619. Dez. 201118. Nov. 2014Digital Signal CorporationSystem and method for providing chirped electromagnetic radiation
US889786812. Sept. 200825. Nov. 2014Medtronic, Inc.Medical device automatic start-up upon contact to patient tissue
US890015424. Mai 20052. Dez. 2014Cardiac Pacemakers, Inc.Prediction of thoracic fluid accumulation
US890349112. Sept. 20132. Dez. 2014Cardiac Pacemakers, Inc.Cardiopulmonary functional status assessment via metabolic response detection by implantable cardiac device
US890933020. Mai 20099. Dez. 2014Sotera Wireless, Inc.Body-worn device and associated system for alarms/alerts based on vital signs and motion
US891574123. Aug. 201123. Dez. 2014Cardiac Pacemakers, Inc.Sleep quality data collection and evaluation
US8915866 *18. Jan. 200823. Dez. 2014Warsaw Orthopedic, Inc.Implantable sensor and associated methods
US893655622. Sept. 200920. Jan. 2015Cardiac Pacemakers, Inc.Minute ventilation-based disordered breathing detection
US89427797. Aug. 201427. Jan. 2015Early Sense Ltd.Monitoring a condition of a subject
US895414616. Apr. 201410. Febr. 2015Cardiac Pacemakers, Inc.Implantable cardiac device with dyspnea measurement
US8954148 *28. Juni 201110. Febr. 2015Greatbatch, Ltd.Key fob controller for an implantable neurostimulator
US895629320. Mai 200917. Febr. 2015Sotera Wireless, Inc.Graphical ‘mapping system’ for continuously monitoring a patient's vital signs, motion, and location
US895629420. Mai 200917. Febr. 2015Sotera Wireless, Inc.Body-worn system for continuously monitoring a patients BP, HR, SpO2, RR, temperature, and motion; also describes specific monitors for apnea, ASY, VTAC, VFIB, and ‘bed sore’ index
US89562959. Sept. 201317. Febr. 2015Cardiac Pacemakers, Inc.Sleep detection using an adjustable threshold
US896549828. März 201124. Febr. 2015Corventis, Inc.Method and apparatus for personalized physiologic parameters
US897193626. Aug. 20103. März 2015Adidas AgMultimodal method and system for transmitting information about a subject
US897976519. Apr. 201017. März 2015Sotera Wireless, Inc.Body-worn monitor for measuring respiratory rate
US89924341. Apr. 201431. März 2015Earlysense Ltd.Prediction and monitoring of clinical episodes
US899882126. Juli 20137. Apr. 2015Cardiac Pacemakers, Inc.Systems and methods for determining respiration metrics
US899883013. Aug. 20147. Apr. 2015Earlysense Ltd.Monitoring, predicting and treating clinical episodes
US901481912. Nov. 201321. Apr. 2015Cardiac Pacemakers, Inc.Autonomic arousal detection system and method
US90261992. Dez. 20145. Mai 2015Earlysense Ltd.Monitoring a condition of a subject
US90577337. März 201316. Juni 2015Critical Care Diagnostics, Inc.Predicting mortality and detecting severe disease
US907903320. Jan. 200914. Juli 2015Cardiac Pacemakers, Inc.Respiration as a trigger for therapy optimization
US908927511. Mai 200528. Juli 2015Cardiac Pacemakers, Inc.Sensitivity and specificity of pulmonary edema detection when using transthoracic impedance
US913190218. Febr. 201515. Sept. 2015Earlysense Ltd.Prediction and monitoring of clinical episodes
US913815128. Jan. 201422. Sept. 2015Cardiac Pacemakers, Inc.Method and apparatus for management of heart failure hospitalization
US914071227. Apr. 201122. Sept. 2015Samir SoferImmune and oxygen system measuring and drug screening method and apparatus
US916170030. Dez. 200920. Okt. 2015Sotera Wireless, Inc.Body-worn system for measuring continuous non-invasive blood pressure (cNIBP)
US917359319. Apr. 20103. Nov. 2015Sotera Wireless, Inc.Body-worn monitor for measuring respiratory rate
US917359419. Apr. 20103. Nov. 2015Sotera Wireless, Inc.Body-worn monitor for measuring respiratory rate
US917361523. Sept. 20143. Nov. 2015Medtronic Monitoring, Inc.Method and apparatus for personalized physiologic parameters
US918608912. Sept. 200817. Nov. 2015Medtronic Monitoring, Inc.Injectable physiological monitoring system
US921598630. Dez. 200922. Dez. 2015Sotera Wireless, Inc.Body-worn system for measuring continuous non-invasive blood pressure (cNIBP)
US92393331. Mai 201419. Jan. 2016Critical Care Diagnostics, Inc.Methods of determining efficacy of treatment in a subject having heart failure
US926595012. Mai 200823. Febr. 2016Cardiac Pacemakers, Inc.Contractility modulation based on impedance signal
US92778859. Febr. 20158. März 2016Cardiac Pacemakers, Inc.Implantable cardiac device with dyspnea measurement
US932670526. Aug. 20103. Mai 2016Adidas AgMethod and system for monitoring physiological and athletic performance characteristics of a subject
US933920919. Apr. 201017. Mai 2016Sotera Wireless, Inc.Body-worn monitor for measuring respiratory rate
US936415828. Dez. 201114. Juni 2016Sotera Wirless, Inc.Body-worn system for continuous, noninvasive measurement of cardiac output, stroke volume, cardiac power, and blood pressure
US938095228. Dez. 20115. Juli 2016Sotera Wireless, Inc.Body-worn system for continuous, noninvasive measurement of cardiac output, stroke volume, cardiac power, and blood pressure
US941193612. Sept. 20089. Aug. 2016Medtronic Monitoring, Inc.Dynamic pairing of patients to data collection gateways
US943957417. Febr. 201213. Sept. 2016Sotera Wireless, Inc.Modular wrist-worn processor for patient monitoring
US94518972. Dez. 201027. Sept. 2016Medtronic Monitoring, Inc.Body adherent patch with electronics for physiologic monitoring
US949209220. Mai 200915. Nov. 2016Sotera Wireless, Inc.Method for continuously monitoring a patient using a body-worn device and associated system for alarms/alerts
US951077916. Sept. 20106. Dez. 2016Masimo CorporationAnalyte monitoring using one or more accelerometers
US952641926. Aug. 201027. Dez. 2016Adidas AgGarment for physiological characteristics monitoring
US953896023. Okt. 201510. Jan. 2017Medtronic Monitoring, Inc.Injectable physiological monitoring system
US954522226. Aug. 201017. Jan. 2017Adidas AgGarment with noninvasive method and system for monitoring physiological characteristics and athletic performance
US956848126. Okt. 201114. Febr. 2017Critical Care Diagnostics, Inc.Methods of identifying a subject as having heart failure
US957902024. Mai 201328. Febr. 2017Medtronic Monitoring, Inc.Adherent cardiac monitor with advanced sensing capabilities
US958557728. Dez. 20117. März 2017Sotera Wireless, Inc.Body-worn system for continuous, noninvasive measurement of cardiac output, stroke volume, cardiac power, and blood pressure
US959699914. Sept. 200921. März 2017Sotera Wireless, Inc.Body-worn pulse oximeter
US961575720. Juni 201411. Apr. 2017Medtronic Monitoring, Inc.Method and apparatus for remote detection and monitoring of functional chronotropic incompetence
US966865630. Dez. 20096. Juni 2017Sotera Wireless, Inc.Body-worn system for measuring continuous non-invasive blood pressure (cNIBP)
US970021512. Okt. 201311. Juli 2017Makaha Medical, Llc.Systems and methods for assessing vasculature health and blood clots
US973059230. Juli 201515. Aug. 2017Cardiac Pacemakers, Inc.Method and apparatus for management of heart failure hospitalization
US97438894. Aug. 201429. Aug. 2017Cardiac Pacemakers, Inc.System and method for detecting worsening of heart failure based on rapid shallow breathing index
US20030028221 *31. Juli 20016. Febr. 2003Qingsheng ZhuCardiac rhythm management system for edema
US20030191503 *11. Apr. 20039. Okt. 2003Cardiac Pacemakers, Inc.Cardiac rhythm management system for edema
US20050039745 *18. Aug. 200324. Febr. 2005Stahmann Jeffrey E.Adaptive therapy for disordered breathing
US20050043644 *18. Aug. 200324. Febr. 2005Stahmann Jeffrey E.Prediction of disordered breathing
US20050043772 *18. Aug. 200324. Febr. 2005Stahmann Jeffrey E.Therapy triggered by prediction of disordered breathing
US20050065567 *31. Aug. 200424. März 2005Cardiac Pacemakers, Inc.Therapy control based on cardiopulmonary status
US20050065572 *30. Aug. 200424. März 2005Cardiac Pacemakers, Inc.Diagnosis and/or therapy using blood chemistry/expired gas parameter analysis
US20050080348 *17. Aug. 200414. Apr. 2005Stahmann Jeffrey E.Medical event logbook system and method
US20050081847 *20. Aug. 200421. Apr. 2005Kent LeeAutomatic activation of medical processes
US20050192508 *31. Jan. 20051. Sept. 2005Earlysense Ltd.Techniques for prediction and monitoring of respiration-manifested clinical episodes
US20050240093 *10. März 200527. Okt. 2005Dearmond Daniel TIntracorporeal impedance and leak monitoring device
US20060074326 *21. Sept. 20056. Apr. 2006Sebastian Richard LSystem and method for remotely monitoring physiological functions
US20060122863 *20. Jan. 20058. Juni 2006Medtronic, Inc.Patient management network
US20060122864 *20. Jan. 20058. Juni 2006Gottesman Janell MPatient management network
US20060203224 *14. Febr. 200614. Sept. 2006Richard SebastianChirped coherent laser radar system and method
US20060224076 *2. Juni 20065. Okt. 2006Earlysense Ltd.Techniques for prediction and monitoring of respiration-manifested clinical episodes
US20060241510 *3. Aug. 200526. Okt. 2006Earlysense Ltd.Techniques for prediction and monitoring of clinical episodes
US20060253042 *4. Mai 20059. Nov. 2006Stahmann Jeffrey ESyncope logbook and method of using same
US20060258952 *11. Mai 200516. Nov. 2006Cardiac Pacemakers, Inc.Enhancements to the detection of pulmonary edema when using transthoracic impedance
US20060293609 *11. Mai 200528. Dez. 2006Cardiac Pacemakers, Inc.Sensitivity and specificity of pulmonary edema detection when using transthoracic impedance
US20070021678 *19. Juli 200525. Jan. 2007Cardiac Pacemakers, Inc.Methods and apparatus for monitoring physiological responses to steady state activity
US20070073168 *16. Sept. 200529. März 2007Yi ZhangRapid shallow breathing detection for use in congestive heart failure status determination
US20070106130 *4. Jan. 200710. Mai 2007Cardiac Pacemakers, Inc.Detection of congestion from monitoring patient response to a recumbent position
US20070123754 *29. Nov. 200531. Mai 2007Cuddihy Paul ENon-encumbering, substantially continuous patient daily activity data measurement for indication of patient condition change for access by remote caregiver
US20070129641 *1. Dez. 20057. Juni 2007Sweeney Robert JPosture estimation at transitions between states
US20070129643 *1. Dez. 20057. Juni 2007Jonathan KwokMethod and system for heart failure status evaluation based on a disordered breathing index
US20070171367 *14. Dez. 200626. Juli 2007Digital Signal CorporationSystem and method for tracking eyeball motion
US20070189341 *14. Febr. 200616. Aug. 2007Kendall BelsleySystem and method for providing chirped electromagnetic radiation
US20070239057 *29. März 200611. Okt. 2007Yanchuan PuPeriodic disordered breathing detection
US20070248981 *24. Apr. 200725. Okt. 2007Snider James VPredicting mortality and detecting severe disease
US20070270674 *17. Mai 200622. Nov. 2007Michael John KaneImplantable Medical Device with Chemical Sensor and Related Methods
US20070270675 *17. Mai 200622. Nov. 2007Michael John KaneImplantable Medical Device with Chemical Sensor and Related Methods
US20070282215 *6. Aug. 20076. Dez. 2007Cardiac Pacemakers, Inc.Detection of disordered breathing
US20080132802 *11. Febr. 20085. Juni 2008Quan NiSystem And Method For Determining Pulmonary Performance From Transthoracic Impedance Measures
US20080193914 *6. Apr. 200714. Aug. 2008Randall ThomasonBiomarker derivation method
US20080249586 *16. Juni 20089. Okt. 2008Cardiac Pacemakers, Inc.Cardiopulmonary functional status assessment via metabolic response detection by implantable cardiac device
US20080269625 *25. Juli 200730. Okt. 2008Earlysense Ltd.Prediction and monitoring of clinical episodes
US20080319797 *5. Dez. 200625. Dez. 2008Koninklijke Philips Electronics, N.V.Chronic Illness Goal Management
US20090112116 *22. Dez. 200830. Apr. 2009Kent LeeSystem And Method For Discrimination Of Central And Obstructive Disordered Breathing Events
US20090124875 *12. Nov. 200814. Mai 2009Cardiac Pacemakers, Inc.Implantable Creatinine Sensor and Related Methods
US20090125328 *12. Nov. 200714. Mai 2009Air Products And Chemicals, Inc.Method and System For Active Patient Management
US20090153872 *26. Febr. 200918. Juni 2009Digital Signal CorporationChirped coherent laser radar system and method
US20090187120 *18. Jan. 200823. Juli 2009Warsaw Orthopedic, Inc.Implantable sensor and associated methods
US20090216093 *26. Febr. 200927. Aug. 2009Digital Signal CorporationSystem and method for remotely monitoring physiological functions
US20090234240 *20. Jan. 200917. Sept. 2009Kuenzler Richard ORespiration as a Trigger for Therapy Optimization
US20090264337 *21. Apr. 200922. Okt. 2009Kimon AngelidesCellular GPRS-communication linked glucometer - pedometer
US20090305265 *27. Apr. 200710. Dez. 2009Critical Care Diagnostics, Inc.Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease
US20090312660 *17. Juni 200817. Dez. 2009Biorics NvRecognition and localisation of pathologic animal and human sounds
US20100009356 *1. Mai 200714. Jan. 2010Critical Care Diagnostics, Inc.Diagnosis of cardiovascular disease
US20100010378 *21. Aug. 200914. Jan. 2010Hatlestad John DApparatus and Method for Detecting Lung Sounds Using an Implanted Device
US20100055683 *2. Mai 20074. März 2010Critical Care Diagnostics, Inc.Diagnosis of pulmonary and/or cardiovascular disease
US20100056929 *11. Nov. 20094. März 2010Stahmann Jeffrey ESyncope Logbook and Method of Using Same
US20100100000 *22. Sept. 200922. Apr. 2010Kent LeeMinute Ventilation-Based Disordered Breathing Detection
US20100131434 *24. Nov. 200827. Mai 2010Air Products And Chemicals, Inc.Automated patient-management system for presenting patient-health data to clinicians, and methods of operation thereor
US20100137730 *5. Febr. 20103. Juni 2010John HatlestadSystems and Methods for Determining Respiration Metrics
US20100160992 *28. Mai 200724. Juni 2010St. Jude Medical AbImplantable medical device, system and method
US20100228103 *5. März 20099. Sept. 2010Pacesetter, Inc.Multifaceted implantable syncope monitor - mism
US20100298655 *20. Mai 200925. Nov. 2010Triage Wireless , Inc.Method for measuring patient posture and vital signs
US20100298732 *30. Juli 201025. Nov. 2010Yi ZhangRapid Shallow Breathing Detection for use in Congestive Heart Failure Status Determination
US20100298733 *30. Juli 201025. Nov. 2010Jonathan KwokMethod and System for Heart Failure Status Evaluation Based on a Disordered Breathing Index
US20100324438 *30. Juli 201023. Dez. 2010Quan NiDetection of Disordered Breathing
US20110040201 *25. Okt. 201017. Febr. 2011Yanchuan PuPeriodic Disordered Breathing Detection
US20110050216 *26. Aug. 20103. März 2011Adidas AgMethod And System For Limiting Interference In Magnetometer Fields
US20110053170 *10. Nov. 20103. März 2011Snider James VInterleukin-33 (IL-33) for the Diagnosis and Prognosis of Cardiovascular Disease
US20110054270 *26. Aug. 20103. März 2011Adidas AG, World of SportsMultimodal Method And System For Transmitting Information About A Subject
US20110054271 *26. Aug. 20103. März 2011Adidas AgNoninvasive Method And System For Monitoring Physiological Characteristics
US20110054272 *26. Aug. 20103. März 2011Adidas AG, World of SportsMethod And System For Monitoring Physiological And Athletic Performance Characteristics Of A Subject
US20110054289 *26. Aug. 20103. März 2011Adidas AG, World of SportsPhysiologic Database And System For Population Modeling And Method of Population Modeling
US20110054290 *26. Aug. 20103. März 2011Adidas AG, World of SportsMethod and System for Interpretation and Analysis of Physiological, Performance, and Contextual Information
US20110105861 *31. Aug. 20105. Mai 2011Adidas Ag World Of SportsPhysiological Monitoring Garment
US20110130643 *26. Aug. 20102. Juni 2011Adidas AgNoninvasive Method And System For Monitoring Physiological Characteristics And Athletic Performance
US20110169725 *13. März 200714. Juli 2011Hiromu UeshimaFunction measuring device
US20110184267 *26. Jan. 201028. Juli 2011Roche Diagnostics Operations, Inc.Methods And Systems For Processing Glucose Data Measured From A Person Having Diabetes
US20110201955 *26. Apr. 201118. Aug. 2011John HatlestadApparatus and Method for Detecting Lung Sounds Using an Implanted Device
US20120245553 *25. März 201127. Sept. 2012Allergan, Inc.Intragastric volume occupying device with active agents
US20130004925 *28. Juni 20113. Jan. 2013Greatbatch, Ltd.Key fob controller for an implantable neurostimulator
CN102740770A *24. Jan. 201117. Okt. 2012霍夫曼-拉罗奇有限公司Methods and systems for processing glucose data measured from a person having diabetes
CN103003698A *27. Apr. 201127. März 2013萨米尔·索弗Immune and oxygen system measuring and drug screening method and apparatus
CN103930763A *29. Juni 201216. Juli 2014联邦科学与工业研究组织System, method and device for measuring a gas in the stomach of a mammal
DE102009008427A1 *11. Febr. 200919. Aug. 2010Schölly Fiberoptic GmbHEndoskop
EP2152362A1 *28. Mai 200717. Febr. 2010St. Jude Medical ABImplantable medical device for monitoring lung deficiency
EP2152362A4 *28. Mai 200715. Sept. 2010St Jude MedicalImplantable medical device for monitoring lung deficiency
EP2289402A131. Aug. 20102. März 2011Adidas AGMethod and system for interpretation and analysis of physiological, performance, and contextual information
EP2289404A11. Sept. 20102. März 2011Adidas AGMulti modal method and system for transmitting information about a subject
EP2505131A121. Juni 20063. Okt. 2012Earlysense, Ltd.Techniques for prediction and monitoring of clinical episodes
EP2762073A1 *24. Jan. 20116. Aug. 2014Roche Diagnostics GmbHMethods and systems for processing glucose data measured from a person having diabetes
WO2006137067A3 *21. Juni 200627. Sept. 2007Earlysense LtdTechniques for prediction and monitoring of clinical episodes
WO2007008057A1 *14. Juli 200518. Jan. 2007Erasmus University Medical Center RotterdamTissue vitality monitoring system and method and surgical technique
WO2007127749A2 *24. Apr. 20078. Nov. 2007Critical Care Diagnostics, Inc.Predicting mortality and detecting severe disease
WO2007127749A3 *24. Apr. 200720. März 2008Critical Care Diagnostics IncPredicting mortality and detecting severe disease
WO2008152433A1 *17. Juni 200818. Dez. 2008Biorics NvRecognition and localisation of pathologic animal and human sounds
WO2008154662A1 *17. Juni 200818. Dez. 2008Biorics NvRecognition and localisation of pathologic animal and human sounds
WO2009036329A112. Sept. 200819. März 2009Corventis, Inc.Multi-sensor patient monitor to detect impending cardiac decompensation
WO2009064773A1 *12. Nov. 200822. Mai 2009Cardiac Pacemakers, Inc.Implantable creatinine sensor and related methods
WO2010135516A3 *20. Mai 20103. Febr. 2011Sotera Wireless, Inc.Vital sign monitoring systems
WO2011035070A1 *16. Sept. 201024. März 2011Masimo Laboratories, Inc.Improving analyte monitoring using one or more accelerometers
WO2011092133A1 *24. Jan. 20114. Aug. 2011Roche Diagnostics GmbhMethods and systems for processing glucose data measured from a person having diabetes
WO2011139733A3 *27. Apr. 201129. März 2012Samir SoferImmune and oxygen system measuring and drug screening method and apparatus
Klassifizierungen
US-Klassifikation600/300
Internationale KlassifikationA61B5/00, A61B5/0205, A61B5/11, A61B5/0456, A61B5/0464, A61B5/08
UnternehmensklassifikationA61B5/14532, A61B5/0809, A61B5/14546, A61B5/11, A61B5/0464, A61B2562/0219, A61B5/0456, A61B5/0031, A61B5/0205
Europäische KlassifikationA61B5/145P, A61B5/00B9, A61B5/0205
Juristische Ereignisse
DatumCodeEreignisBeschreibung
29. Apr. 2003ASAssignment
Owner name: CARDIAC PACEMAKERS, INC., MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAZAR, SCOTT THOMAS;FOGOROS, RICHARD;MANICKA, YATHEENDHAR;AND OTHERS;REEL/FRAME:013994/0965;SIGNING DATES FROM 20030326 TO 20030421